Type
Internal restructuring
Country
Italy
Region
Nord Est; Veneto; Verona
Location of affected unit(s)
Verona
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

550 jobs
Number of planned job losses
Job loss
Announcement Date
4 February 2010
Employment effect (start)
30 April 2010
Foreseen end date

Description

Pharmaceutical company Glaxo Smithline is to cut 550 jobs at its site in Verona. The company will close its research unit with the loss of 550 jobs. Glaxo has around 1,500 employees in Verona. The trade unions and the local authorities disagree with the company's decision.

These job cuts are part of a larger restructuring plan that will result in the loss of around 4,000 jobs worldwide. The bulk of the cuts will be in America and Europe, and are part of the company's efforts to make its research and development arm more cost-efficient. The company also intends to focus increasingly on emerging markets.


Sources

  • 5 February 2010: Il corriere della sera
  • 5 February 2010: La Repubblica

Citation

Eurofound (2010), Glaxo SmithKline, Internal restructuring in Italy, factsheet number 70148, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/70148.